Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport: Permitted Active ingredient: Ethinylestradiol 30μg, gestodene 75μg. Description: White, round, biconvex sugar coated tablets. Presentation: 3 x 21, €7.60. Indications: Oral contraception. Pharmacology: Estelle is a hormonal contraceptive for systemic use. The contraceptive effect of contraceptive pills rests on the interaction of various factors, the most [...]
Moxifloxacin (Avelox) & Hepatic Failure and Serious Skin Reactions
h3. Important Safety Information h4. Moxifloxacin (Avelox) & Hepatic Failure and Serious Skin Reactions Moxifloxacin (Avelox) is an antibacterial medicine authorised in Ireland for the treatment of the following bacterial infections: * Acute exacerbation of chronic bronchitis * Community acquired pneumonia, except severe cases * Acute bacterial sinusitis (adequately diagnosed) Moxifloxacin should only be use [...]
Mircera
Company: Roche Products (Ireland) Ltd. Legal category: Prescription. HT. Sport: Prohibited. Active ingredient: Methoxy polyethylene glycol-epoetin beta 50, 75, 100, 150, 200 and 250μg solution in 0.3ml. Description: Solution for injection in a pre-filled syringe. Presentation: Pack of 1 pre-filled syringe, price available on request. Indications: Treatment of anaemia associated with chronic kidney disease. Pharmacology: [...]
Perdamel
Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport: Permitted Active ingredient: Risperidone 0.5mg, 1mg, 2mg, 3mg, 4mg, 6mg. Description: Brownish-red/white/salmon/yellow/light green or yellow film-coated tablets debossed R and 0.5, 1, 2, 3, 4, 6 respectively. 0.5mg, 1mg, 2mg, 3mg and 4mg are oblong and scored. 6mg is round. Presentation: 0.5mg-20, €11.21; 1mg-20, €14.58; 1mg-60, [...]
Navelbine
Company: Pierre Fabre Ltd. Legal category: Prescription. HT. Sport: Permitted Active ingredient: Vinorelbine 20mg, 30mg. Description: Light brown and pink soft capsule printed N20 and N30, respectively. Presentation: 20mg-1, €65.93; 30mg-1, €98.89. Indications: Treatment of non small cell lung cancer in adult patients. Treatment of advanced breast cancer stage 3 and 4. Pharmacology: Navelbine is [...]
Revlimid
Company: Celgene UK and Ireland Ltd. Legal category: Prescription. HT. Sport permitted. Active ingredient: Lenalidomide 5mg, 10mg, 15mg, 25mg. Description: Capsules marked REV followed by strength. 5mg, white; 10mg, blue-green/pale yellow; 15mg, pale blue/white; 25mg, white. Presentation: 5mg-21, €6085.80; 10mg-21, €6423.90; 15mg- 21, €6762.00; 25mg-21, €7414.05. Indications: Revlimid in combination with dexamethasone is indicated for [...]
Nexavar New Indication
h3. Nexavar Approved in Europe for the Treatment of Patients with Hepatocellular Carcinoma Bayer Schering Pharma wish to announce that Nexavar (sorafenib) has been approved in Europe for the treatment of Hepatocellular Carcinoma (HCC). HCC is the third leading cause of cancer death globally with most deaths occurring within 1 year of diagnosis. No standard [...]
Rasilez
Company: Novartis Ireland Ltd. Legal category: Prescription. GMS. SPORT: Permitted. Active ingredient: Aliskiren 150mg, 300mg. Description: Biconvex film-coated tablets marked NVR on one side. 150mg: Light-pink, round marked IL on reverse. 300mg: Light red, ovaloid marked IU on reverse. Presentation: 150mg-28, €27.09; 300mg-28, €36.00. Indications: Treatment of essential hypertension. Pharmacology: Aliskiren is an orally active, [...]
New Data Supporting Efficacy of Spiriva Respimat
Data Support similar Efficacy in COPD Patients of Tiotropium Administered via the Respimat Soft MistTM Inhaler compared with HandiHaler – Boehringer Ingelheim and Pfizer Healthcare wish to announce the introduction of Spiriva Respimat which uses Respimat Soft Mist Inhaler as a new delivery device for Spiriva (tiotropium bromide). The anticholinergic tiotropium is an established option [...]
News from the World Anti-Doping Agency
Changes to Prohibited List announced by World Anti-Doping Agency – The World Anti-Doping Agency (WADA) has issued a new Prohibited List of Substances and Methods which comes into effect on 1 January 2008. Changes to the Prohibited List are as a result of ongoing reviews by the WADA List Working Group and Health, Medical and [...]